Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1

Microbes and Infection

Volumn 7, Issue 15, 2005, Pages 1541-1550

  Lasaro, Marcio O ^a,b   Diniz, Mariana O ^a   Reyes Sandoval, Arturo ^b,d   Ertl, Hildegund C ^b   Ferreira, Luis C S ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b WISTAR INSTITUTE   (United States)

^c Departamento de Estomatologia   (Brazil)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anti cancer vaccines; DNA vaccines; E6 and E7 oncoproteins; gD; HPV 16; HSV; Papillomavirus

Indexed keywords

CANCER VACCINE; DNA VACCINE; GLYCOPROTEIN D; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENETICS; HERPES SIMPLEX VIRUS 1; HYBRID GENE; IMMUNIZATION; INOCULATION; MAMMAL CELL; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; VACCINATION;

ANIMALIA; HUMAN HERPESVIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 16; MAMMALIA; PAPILLOMAVIRIDAE;

EID: 28944442195     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.05.024     Document Type: Article

References (31)

1. P. Pisani, D.M. Parkin, and J. Ferlay Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden Int. J. Cancer 55 1993 891 903
2. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
3. M. van Ranst, R. Tachezy, and R.D. Burk C. Lacey Papillomavirus Reviews: Current Research on Papillomaviruses 1996 Leeds University Press Leeds 1 19
4. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, and K.V. Shah Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group J. Natl. Cancer Inst. 87 1995 796 802
5. M.O. Lasaro, and H.C. Ertl Human Papillomavirus-associated cervical cancer: Prophylactic and therapeutic vaccines Gene Ther. Mol. Biol. 8 2004 291 306
6. R.R. MacGregor, J.D. Boyer, K.E. Ugen, K.E. Lacy, S.J. Gluckman, M.L. Bagarazzi, M.A. Chattergoon, Y. Baine, T.J. Higgins, R.B. Ciccarelli, L.R. Coney, R.S. Ginsberg, and D.B. Weiner First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J. Infect. Dis. 178 1998 92 100
7. M. Smahel, E. Sobotkova, V. Vonka, E. Hamsikova, R. Zak, H. Kitasato, and V. Ludvikova DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene Oncol. Rep. 6 1999 211 215
8. C.H. Chen, T.L. Wang, C.F. Hung, D.M. Pardoll, and T.C. Wu Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines Vaccine 18 2000 2015 2022
9. W.F. Cheng, C.F. Hung, C.Y. Chai, K.F. Hsu, L. He, M. Ling, and T.C. Wu Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen J. Clin. Invest. 108 2001 669 678
10. C.H. Chen, T.L. Wang, C.F. Hung, Y. Yang, R.A. Young, D.M. Pardoll, and T.C. Wu Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene Cancer Res. 60 2000 1035 1042
11. H. Ji, T.L. Wang, C.H. Chen, S.I. Pai, C.F. Hung, K.Y. Lin, R.J. Kurman, D.M. Pardoll, and T.C. Wu Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors Hum. Gene Ther. 10 1999 2727 2740
12. T.W. Kim, C.F. Hung, D.A. Boyd, L. He, C.T. Lin, D. Kaiserman, P.I. Bird, and T.C. Wu Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6 Cancer Res. 64 2004 400 405
13. C.F. Hung, W.F. Cheng, K.F. Hsu, C.Y. Chai, L. He, M. Ling, and T.C. Wu Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen Cancer Res. 61 2001 3698 3703
14. R.J. Watson, J.H. Weis, J.S. Salstrom, and L.W. Enquist Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli Science 218 1982 381 384
15. A.M. Alves, M.O. Lasaro, D.F. Almeida, L.C. Ferreira, Immunoglobulin G subclass responses in mice immunized with plasmid DNA encoding the CFA/I fimbria of enterotoxigenic Escherichia coli, Immunol. Lett. 62 (1998) 145-149.
16. A.M. Alves, M.O. Lasaro, A.S. Pyrrho, C.R. Gattass, D.F. de Almeida, L.C. Ferreira, Antibody response in mice immunized with a plasmid DNA encoding the colonization factor antigen I of enterotoxigenic Escherichia coli, FEMS Immunol. Med. Microbiol. 23 (1999) 321-330.
17. G.H. Cohen, W.C. Wilcox, D.L. Sodora, D. Long, J.Z. Levin, and R.J. Eisenberg Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells J. Virol. 62 1988 1932 1940
18. F. Sanger, S. Nicklen, and A.R. Coulson DNA sequencing with chain-terminating inhibitors Proc. Natl. Acad. Sci. USA 74 1977 5463 5467
19. K.Y. Lin, F.G. Guarnieri, K.F. Staveley-O'Carroll, H.I. Levitsky, J.T. August, D.M. Pardoll, and T.C. Wu Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen Cancer Res. 56 1996 21 26
20. D.M. Harvey, and A.J. Levine p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts Genes Dev. 5 1991 2375 2385
21. Z. He, A.P. Wlazlo, D.W. Kowalczyk, J. Cheng, Z.Q. Xiang, W. Giles-Davis, and H.C. Ertl Viral recombinant vaccines to the E6 and E7 antigens of HPV-16 Virology 270 2000 146 161
22. M.C. Feltkamp, H.L. Smits, M.P. Vierboom, R.P. Minnaar, B.M. de Jongh, J.W. Drijfhout, J. Ter Schegget, C.J. Melief, and W.M. Kast Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells Eur. J. Immunol. 23 1993 2242 2249
23. A. Lamikanra, Z.K. Pan, S.N. Isaacs, T.C. Wu, and Y. Paterson Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site J. Virol. 75 2001 9654 9664
24. R.W. Overell, K.E. Weisser, and D. Cosman Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells Mol. Cell. Biol. 8 1988 1803 1808
25. A.P. Wlazlo, H. Deng, W. Giles-Davis, and H.C. Ertl DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins Cancer Gene Ther. 11 2004 457 464
26. F. Rodriguez, J. Zhang, and J.L. Whitton DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction J. Virol. 71 1997 8497 8503
27. N. Michel, W. Osen, L. Gissman, T.N.M. Schumacher, H. Zentgraf, and M. Müller Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination Virology 294 2002 47 59
28. C.F. Hung, W.F. Cheng, C.Y. Chai, K.F. Hsu, L. He, M. Ling, and T.C. Wu Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen J. Immunol. 166 2001 5733 5740
29. M.P. Vierboom, M.C. Feltkamp, A. Neisig, J.W. Drijfhout, J. Ter Schegget, J.J. Neefjes, C.J. Melief, and W.M. Kast Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope J. Immunother. 21 1998 399 408
30. G. Pollara, M. Jones, M.E. Handley, M. Rajpopat, A. Kwan, R.S. Coffin, G. Foster, B. Chain, and D.R. Katz Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion J. Immunol. 173 2004 4108 4119
31. G. Campadelli-Fiume, F. Cocchi, L. Menotti, and M. Lopez The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells Rev. Med. Virol. 10 2000 305 319